Similar evidence was reported in clinical research, where serum and liver tissue expression levels of periostin were higher in NAFLD patients in respect to controls (179, 312) and upregulation of periostin depended on the release of pro-inflammatory cytokines in NAFLD patient livers (313). This evidence concerns the gene POSTN and metabolic dysfunction-associated steatotic liver disease.